This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Biopharmaceutical Managed Care Strength Closely Intertwined With Marketplace Success

CHAPEL HILL, N.C., April 19, 2013 /PRNewswire/ -- Managed care operations in the pharmaceutical sector are rapidly growing and have emerged as essential factors for success in the U.S. healthcare marketplace. Due to this rapid growth, pharmaceutical and medical device leaders have placed an increased importance on managed care activities.

While well-planned and executed managed care activities can yield sizeable returns, leaders must adapt and constantly adjust their resource levels to suit marketplace requirements. By observing the managed care activities and resourcing of major biopharmaceutical companies in the United States, executives can assess the efficiency and effectiveness of their managed care groups.

To meet the needs of leaders trying to defend their Managed Care resources and investment levels, research and consulting firm, Best Practices, LLC, conducted a primary research study on the issue. The ensuing report, " Resource Benchmarks for U.S. Pharmaceutical Managed Care Operations," delivers insights into the most effective Managed Care operations, tactics, and activities. It also provides a recent look at staffing and resourcing levels in Managed Care groups of leading U.S. pharmaceutical and biotechnology companies.

Key study topics include:

  • Overall Staffing Levels
  • Outsourcing Levels
  • Staffing Levels Per Key Activity
  • Staffing Levels Linked to Brands Supported
  • Financial Investment for U.S. Managed Care Group and Key Activities
  • Staffing Efficiency Measures

The full report contains more than 110 benchmark metrics and critical best practices and identifies industry standards for staffing, outsourcing, budget, and efficiency metrics. Collected benchmarks focused exclusively on interviews with 12 participating executives from leading companies across the pharmaceutical, biotech and medical device industries.

For more information on this study or other recent primary research studies, contact us at 919.403.0251 or visit our website at Best Practices, LLC. Check out Best Practices' blog at www.whybenchmarking.com.

ABOUT BEST PRACTICES, LLCBest Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

SOURCE Best Practices, LLC

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,804.71 -238.19 -1.40%
S&P 500 1,946.16 -26.13 -1.32%
NASDAQ 4,422.0850 -71.3050 -1.59%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs